A Study to Evaluate EDP 938 Regimens in Children With RSV

Status:
Recruiting

Trial end date:
2022-12-01

Target enrollment:

Participant gender:

A 2-part study to evaluate the safety, pharmacokinetics and efficacy of EDP-938 in children with RSV infection.

Phase 2

Enanta Pharmaceuticals